Menu
Mesothelioma Support Yorkshire
Close

Medical
Resources

  • BTS Guideline for the Investigation and Management of Pleural Mesothelioma

     

    Surgical Trials 

    • MARS Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study. Click here to learn more.

    • MARS2 Mesothelioma and Radical Surgery 2 (MARS 2): protocol for a multicentre randomised trial comparing (extended) pleurectomy decortication versus no (extended) pleurectomy decortication for patients with malignant pleural mesothelioma. Click here to learn more.

     

    Systemic Therapy Trials

    • Pemetrexed & Cisplatin Pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. Click here to learn more.
    • CONFIRM Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM). Click here to learn more.
    • Checkmate 743 First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): Click here to learn more.
    • VIM Vinorelbine in Mesothelioma (VIM): A Randomised Phase II Trial of Oral Vinorelbine as Second-Line Therapy for Patients with Malignant Pleural Mesothelioma. Click here to learn more.

     

    Radiotherapy Trials

    • Prophylactic Radiotherapy Prophylactic Irradiation of Tracts (PIT) in Patients with Pleural Mesothelioma: Results of a Multicenter Phase III Trial. Click here to learn more.
    • Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART). Click here to learn more.

     

    Mesothelioma UK Research Centre - Sheffield University

    • Gender and the experiences of living with mesothelioma. Click here to learn more.

    • Living with mesothelioma: A qualitative study of the experiences of male military veterans in the UK. Click here to learn more.

    •  Communication of a mesothelioma diagnosis: developing recommendations to improve the patient experience. Click here to learn more.

    •  Understanding the palliative care needs and experiences of people with mesothelioma and their family carers. Click here to learn more.

    •  Patient experiences of participation in a radical thoracic surgical trial: findings from the Mesothelioma and Radical Surgery Trial (MARS 2). Click here to learn more.

  • If you would like to know more about the Group, would like to attend but might have difficulty getting to Leeds City Centre or have any questions about the Group please contact Simon Bolton on 0142 355 5872 or his mobile: 0787 551 1323

Tweets by MesoYorkshire